Kunihiro Nabeshima
Overview
Explore the profile of Kunihiro Nabeshima including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
55
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagaoka I, Nabeshima K, Murakami S, Yamamoto T, Watanabe K, Tomonaga A, et al.
Exp Ther Med
. 2012 Sep;
1(5):817-827.
PMID: 22993606
We aimed to investigate whether a supplementary diet containing chicken comb extract (CCE) rich in hyaluronic acid (HA) has an effect on pain and other symptoms, as well as cartilage...
2.
Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, et al.
Ther Apher Dial
. 2010 Dec;
14(5):451-6.
PMID: 21175542
Aggressive removal of circulating free light chains (FLC) by blood purification accompanied by chemotherapy is a promising approach for the treatment of acute renal failure due to myeloma cast nephropathy....
3.
Yuzawa Y, Hasegawa M, Nabeshima K
Nihon Jinzo Gakkai Shi
. 2010 Nov;
52(7):894-8.
PMID: 21077337
No abstract available.
4.
Hasegawa M, Nishii C, Ohashi A, Tomita M, Nakai S, Murakami K, et al.
Nephron Clin Pract
. 2009 Aug;
113(3):c222-33.
PMID: 19690440
Background/aims: To clarify the clinical significance of tumor necrosis factor (TNF) receptors in patients with myeloperoxidase (MPO)-anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, we evaluated the cell surface expression of TNF receptor...
5.
Murakami K, Nakanishi Y, Wakamatsu K, Yamamoto K, Kohriyama N, Hasegawa M, et al.
Blood Purif
. 2009 Aug;
28(3):209-15.
PMID: 19648740
Background: Diffuse hyperpigmentation is common in patients with chronic renal failure undergoing hemodialysis (HD) or peritoneal dialysis (PD). We previously reported that serum levels of 5-S-cysteinyldopa (5SCD, a pheomelanin precursor)...
6.
Hiki Y, Takahashi K, Shimozato S, Odani H, Yamamoto K, Tomita M, et al.
Clin Exp Nephrol
. 2008 Jan;
12(1):20-7.
PMID: 18175057
Background: The KM mouse lacks endogenous genes for immunoglobulins and carries the entire human IgH locus and the IgLk transgene. Therefore, human IgA1 does not provoke a hetero-immune response. We...
7.
Murakami K, Tomita M, Kawamura N, Hasegawa M, Nabeshima K, Hiki Y, et al.
Clin Exp Nephrol
. 2007 Sep;
11(3):225-229.
PMID: 17891350
We report a case of a 59-year-old woman who had severe metabolic acidosis and hypokalemia due to an enterovesical fistula. The patient came to our hospital complaining of systemic weakness...
8.
Hasegawa M, Nishii C, Kabutan N, Kato M, Ohashi A, Nakai S, et al.
Ther Apher Dial
. 2007 Sep;
11(5):337-40.
PMID: 17845393
To evaluate the therapeutic potential of cytapheresis in myeloperoxidase-antineutrophil cytoplasmic autoantibody (MPO-ANCA)-associated vasculitis, plasma levels of soluble tumor necrosis factor receptors (sTNFR1, sTNFR2) and the expression of TNFR1, TNFR2, and...
9.
Murakami K, Ohashi A, Hori H, Hibiya M, Shoji Y, Kunisaki M, et al.
Blood Purif
. 2007 Jul;
25(3):290-4.
PMID: 17622711
Bisphenol A [BPA, 2,2-bis(4-hydoxyphenyl)propane], an industrial chemical used in the production of polycarbonate, epoxide resin, and polyarylate, is considered to be an endocrine-disrupting chemical. BPA may be present in some...
10.
Hasegawa M, Ohashi A, Kabutan N, Hiramatsu S, Kato M, Murakami K, et al.
Ther Apher Dial
. 2006 Nov;
10(5):412-8.
PMID: 17096695
Twenty-one patients with myeloperoxidase-antineutrophil cytoplasmic autoantibody (MPO-ANCA)-associated vasculitis were treated using cytapheresis. Of these, 17 were treated for glomerulonephritis and four were treated for pulmonary hemorrhage. The overall survival rate...